Behandling med fluoropyromidin har været ledsaget af kardiotoksicitet, inklusiv myokardieinfarkt, angina pectoris, dysrytmier, kardiogent chok, pludselig død og elektrokardiografiske ændringer.
Cardiotoxicity has been associated with fluoropyrimidine therapy, including myocardial infarction, angina, dysrhythmias, cardiogenic shock, sudden death and electrocardiographic changes.